Skip to main content

Brian Corvino | Principal | Deloitte Consulting LLP

Brian brings almost 20 years of Life Sciences Commercial and Market Access Strategy experience, having served most of the world’s largest life sciences clients, in the areas of market access, commercial and launch strategy. He has dedicated his career to advancing new perspectives on the growing challenge of sustainable affordability, access, and value capture for traditional, specialty, oncology and increasingly transformative drug therapies in cell & gene therapy and rare diseases – having served >250 unique products.

Brian leads Deloitte’s US Market Access practice.  In addition, Brian chair’s Deloitte’s Value and Access Industry group for Cell and Gene Therapy Access.

Prior to joining Deloitte, Brian served as Executive Vice President and Managing Partner at Decision Resources Group (acquired by Clarivate Analytics).  In this capacity, Brian was responsible for guiding both operations and strategy for DRG’s overall Commercial and Market Access business across advisory services, data & analytics, as well as advising clients on strategic commercial issues. Prior to consulting, Brian was a member of the Leadership Development Program at Johnson & Johnson (Janssen) and supported specialty sales, business analytics and strategic planning.

Brian has a passion for leadership development, coaching and mentoring and has been recognized by PharmaVoice as a Top 100 "Most Inspiring Leader" in the Life Sciences Industry.  He continues to actively teach at several leading global  universities, including assignment at the Wharton Business School at the University of Pennsylvania.   In addition, Brian actively serves on the Boards for both the Wharton Healthcare Management Alumni Association and Moravian College Board of Trustees.